As medicine targets personal DNA profiles, York researchers examine ethics and patient experiencesAugust 04, 2004Researchers at the University of York are beginning a major study into the ethical and personal issues raised by a potential revolution in healthcare, which could incorporate individualised medical care - pharmacogenetics - into clinical practice. The use of genetic testing as a routine part of medical treatment opens exciting horizons, but brings with it the responsibility to understand the concerns individuals may have about DNA sampling, and about wider issues such as the possible impact of genetic information. Much of the science of pharmacogenetics is known, but there are many potential hurdles to overcome before the technology is introduced into routine medical use. Over the next three years Professor Andrew Webster, Dr Graham Lewis and a team in the Science and Technology Studies Unit (SATSU) at York will work with colleagues across the UK monitoring patients' reactions to warfarin, commonly used to prevent blood clots. The team from York will interview some of the 2,400 patients who will be selected for the study. Of the 2,400 patients, 2000 will be hospital-based and 400 will be recruited through GP surgeries as warfarin can be prescribed by GPs. Patients' responses will be mapped against their personal DNA profiles and the SATSU team will interview them to see how they feel about DNA samples being taken, and how publicly acceptable this would be, and the hurdles to introducing the technique. Warfarin is a very useful drug currently taken by 600,000 patients in the UK, but a small proportion of those who take it suffer serious side effects, even sometimes death. If a patient's genetic makeup is known beforehand, doctors can prescribe far more accurately so that there are fewer serious side effects. But the serious ethical issues to be considered, such as reading individual genetic codes from DNA samples, affect both patients and the clinical staff who will have to introduce the new and complex technologies. Clinical staff experiences of these processes are also examined through interviews. Dr Lewis commented; "it is important to study how attitudes and perceptions change with the introduction of new medical technologies like pharmacogenetics, and that means studying the experiences of doctors and nursing staff as well as patients." Dr Lewis added: "It's been known for a long time that an individual's genetic make-up affects the way they respond to medicines, both in terms of the likelihood of adverse side effects, and whether they respond to treatment. Pharmacogenetics, or so-called personalised medicine, offers the exciting possibility of individualised treatment. "This could revolutionise medical care, giving doctors the ability to prescribe the best drug for their patient without trial and error. "But there are major considerations - confidentiality, the impact of the genetic information on the patient, and the implications for their families. "We need to understand how people will view this new development. "There are also cost implications - is it worthwhile introducing pharmacogenetics? There is no real evidence yet from large-scale trials. We need to recognise that many other factors such as diet, lifestyle and age affect a patient's response to warfarin treatment." The genetic profiling of patients taking part in the study will not influence their own treatment but will hopefully help future warfarin users. The teams involved in the study will share £840,000 in research funding from the Department of Health. | |||||||||||||||||||||
|
Related DNA Current Events and DNA News Articles Protein's essential role in repairing damaged cells revealed University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer. Genetic mutation causes familial susceptibility for degenerative brain disease Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE). NYU scientists discover dangerous new method for bacterial toxin transfer Scientists have discovered a new way for bacteria to transfer toxic genes to unrelated bacterial species, a finding that raises the unsettling possibility that bacterial swapping of toxins and other disease-aiding factors may be more common than previously imagined. Plant polymerases IV and V are special forms of Polymerase II It's a little like finding out that Superman is actually Clark Kent. A team of biologists at Washington University in St. Louis has discovered that two vital cellular components, nuclear RNA Polymerases IV and V (Pol IV and V), found only in plants, are actually specialized forms of RNA Polymerase II, an essential enzyme of all eukaryotic organisms, including humans. Evolution in action: Our antibodies take 'evolutionary leaps' to fight microbes With cold and flu season in full swing, the fact that viruses and bacteria rapidly evolve is apparent with every sneeze, sniffle, and cough. A new report in the January 2009 issue of The FASEB Journal, explains for the first time how humans keep up with microbes by rearranging the genes that make antibodies to foreign invaders. This research fills a significant gap in our understanding of how the immune system helps us survive. Team finds breast cancer gene linked to disease spread A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death. Collagen VI may help protect the brain against Alzheimer's disease Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta (Aβ) proteins, which are widely thought to cause Alzheimer's disease (AD). Testes stem cell can change into other body tissues, Stanford/UCSF study shows Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes. Understanding Extinct Microbes May Influence the State of Modern Human Health The study of ancient microbes may not seem consequential, but such pioneering research at the University of Oklahoma has implications for the state of modern human health. Cecil Lewis, assistant professor in the Department of Anthropology, says results of this research raise questions about the microbes living on and within people. In lung cancer, silencing one crucial gene disrupts normal functioning of genome While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism. More DNA Current Events and DNA News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||